As investors continue to debate whether the stock market could be near a bottom, data for the last twelve bear markets indicates that, on average, it took the Dow three years to reach its previous highs.
Although the health care industry is not immune to a sluggish economy, the sector presents some attractive opportunities, said Carl McDonald, a senior analyst at Oppenheimer & Co.
This content is only available online - you won't find these trades on TV.
Stocks finished lower Monday, as weakness in financials and energy stocks overpowered a sharp drop in oil price typical of what usually pushes the market higher.
Stocks were lackluster Monday despite a massive move downward for oil, as worries persisted over inflation and the nation's beaten-up housing and mortgage markets.
Health care stocks have been the stealth performers, and they will likely continue to outperform because of steady earnings, a favorable macro environment and cheap valuations, says Merrill Lynch's Brian Belski.
That sinking feeling: Kirby Daley, strategist at the Newedge Group, says the U.S. is in recession and he expects a 15 percent to 20 percent drop in the Dow -- in the near future.
Mixed economic news this morning, as personal income and spending was better than expected; but a measure of inflation was stronger than expected. And once again, bank jitters are an issue for the market.
Health insurer Humana posted quarterly profit that beat estimates and lifted its 2008 forecast on Monday on better-than-expected results for its Medicare prescription drug plans for seniors, sending shares more than 4 percent higher.
Brent Wilsey has a prescription for investors: Specialty health-care names. The president of Wilsey Asset Management thinks that the downdrafts that have slammed stock prices in the sector are now behind it, and it's time to buy into the companies' recovery.
Cramer last week offered up his prediction of potential winners from the new Medicare bill -- the one that passed in the Senate yesterday. (President Bush has said he'll veto -- but it already passed by a veto-proof margin.) The good news is that Fresenius Med (FMS), Cramer's fave of the bill, got bumped to a 52-week high today with three points. But what about the losers of the Medicare bill -- the new offenders headed for the Sell Block?
Viewers ask Cramer the essential question: Am I diversified?
Aetna shares dropped 5 percent and Health Net tumbled 10 percent after a Goldman Sachs analyst slapped "sell" ratings on the two health insurers' stocks Thursday.
It was a mixed day, which started poorly with a big earnings warning from HMO Coventry, as well as Burlington Northern and Smucker's, which noted higher soybean oil and wheat costs were hurting their bottom line.
After the close today, Coventry Health Care slashed its Q2 and full-year earnings guidance due to increasing cost pressures. Coventry’s stock was halted after hours before starting again. Meanwhile, other healthcare stocks are trading sharply lower in after hours trading following the news.
I had a visit on Power Lunch today and we talked about the effect on the health care stocks depending on who wins the White House. In general, pharmaceutical companies do well when they have a new product pipeline of innovative products that allow them to command high prices.
The Dow ended higher Tuesday led by technology companies as a sharp drop in crude oil prices rekindled hopes of increased consumer and business spending on tech gear...
Following are the day’s biggest winners and losers. Find out why shares of Humana and Medtronic popped while DryShips and J.C. Penney dropped.
Following are the day’s biggest winners and losers. Find out why shares of Apple and Sysco popped while Goodyear Tire and Alberto-Culver dropped.
It's a booyah-free zone. There goes Swifty!